StockData
AtriCure, Inc. logo

AtriCure, Inc. (ATRC) stock

ATRCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/30893% above fair value
$55.02−0.29 (-0.52%)

Close on Nov 17, 2026Market cap $2.80BP/E 262.0Yield –

AtriCure total assets

Total assets on the balance sheet at the end of each period.

AtriCure's total assets was $676.64M at Jun 30, 2026. For fiscal 2025 it was $654.18M, up 7.4% from the year before. Over ten years it grew 9.1% a year on average. The highest annual figure on record is $714.54M in fiscal 2020.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$654.18M+7.4%
FY2024Dec 31, 2024$609.33M-0.7%
FY2023Dec 31, 2023$613.93M+4.9%
FY2022Dec 31, 2022$585.45M-4.9%
FY2021Dec 31, 2021$615.31M-13.9%
FY2020Dec 31, 2020$714.54M+28.1%
FY2019Dec 31, 2019$557.88M+56.4%
FY2018Dec 31, 2018$356.76M+33.3%
FY2017Dec 31, 2017$267.70M-3.2%
FY2016Dec 31, 2016$276.42M+1.2%
FY2015Dec 31, 2015$273.09M+72.4%
FY2014Dec 31, 2014$158.40M+41.5%
FY2013Dec 31, 2013$111.95M+245.2%
FY2012Dec 31, 2012$32.43M-4.2%
FY2011Dec 31, 2011$33.86M+0.4%
FY2010Dec 31, 2010$33.72M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$676.64M+11.1%
Q1 FY2026Mar 31, 2026$643.99M+8.8%
Q4 FY2025Dec 31, 2025$654.18M+7.4%
Q3 FY2025Sep 30, 2025$635.44M+3.3%
Q2 FY2025Jun 30, 2025$608.85M+1.9%
Q1 FY2025Mar 31, 2025$591.63M+0.0%
Q4 FY2024Dec 31, 2024$609.33M-0.7%
Q3 FY2024Sep 30, 2024$615.07M+2.5%
Q2 FY2024Jun 30, 2024$597.27M+0.5%
Q1 FY2024Mar 31, 2024$591.63M+1.5%
Q4 FY2023Dec 31, 2023$613.93M+4.9%
Q3 FY2023Sep 30, 2023$600.27M+3.2%
Q2 FY2023Jun 30, 2023$594.17M+1.2%
Q1 FY2023Mar 31, 2023$583.10M-0.3%
Q4 FY2022Dec 31, 2022$585.45M-4.9%
Q3 FY2022Sep 30, 2022$581.91M-5.1%
Q2 FY2022Jun 30, 2022$587.39M-16.2%
Q1 FY2022Mar 31, 2022$584.98M-16.4%
Q4 FY2021Dec 31, 2021$615.31M-13.9%
Q3 FY2021Sep 30, 2021$612.97M-13.4%
Q2 FY2021Jun 30, 2021$701.08M-0.4%
Q1 FY2021Mar 31, 2021$699.90M+32.6%
Q4 FY2020Dec 31, 2020$714.54M+28.1%
Q3 FY2020Sep 30, 2020$707.80M+26.2%
Q2 FY2020Jun 30, 2020$704.23M+105.2%
Q1 FY2020Mar 31, 2020$527.73M+56.0%
Q4 FY2019Dec 31, 2019$557.88M+56.4%
Q3 FY2019Sep 30, 2019$560.76M+106.2%
Q2 FY2019Jun 30, 2019$343.12M+26.7%
Q1 FY2019Mar 31, 2019$338.36M+25.5%
Q4 FY2018Dec 31, 2018$356.76M+33.3%
Q3 FY2018Sep 30, 2018$271.96M+1.3%
Q2 FY2018Jun 30, 2018$270.85M+0.9%
Q1 FY2018Mar 31, 2018$269.70M+1.2%
Q4 FY2017Dec 31, 2017$267.70M-3.2%
Q3 FY2017Sep 30, 2017$268.45M-3.9%
Q2 FY2017Jun 30, 2017$268.51M–
Q1 FY2017Mar 31, 2017$266.42M–
Q4 FY2016Dec 31, 2016$276.42M–
Q3 FY2016Sep 30, 2016$279.32M–

More AtriCure figures

See a number that looks wrong?